Breaking News

House Energy & Commerce Committee Votes in Favor of MAT Act Amendments, Paving Way for House Vote

Published: May 19, 2022
May 19, 2022 On May 18th, the U.S. House Energy and Commerce Committee voted to approve an amendment to the Mainstreaming Addiction Treatment (MAT) Act, to remove the buprenorphine X-Waiver, and to move the MAT Act out of committee. The Committee, Chaired by Representative Frank Pallo...

Biden Administration Releases New Housing Supply Action Plan

Published: May 17, 2022
May 17, 2022 Today, the Biden Administration released a new Housing Supply Action Plan with the aim of closing the housing supply gap in five years. This plan, part of the Administration's efforts to combat inflation, looks to ...

NJ Cannabis Regulatory Commission Faces Harsh Questioning during Senate Judiciary Committee Hearing

Updated: May 16, 2022
May 16, 2022 On Thursday, May 12, 2022, the New Jersey Senate Judiciary Committee held a hearing that primarily scrutinized and raised concerns about the New Jersey Cannabis Regulatory Commission's (CRC's) rollout of legal marijuana in the state. The hearing, which lasted five hours, ...

FDA Approves Olumiant for COVID-19 Treatment

Published: May 12, 2022
May 12, 2022 On Wednesday, the U.S. Food and Drug Administration (FDA) announced approval of a new indication, or justification for prescription, of the drug Olumiant (baricitinib) for treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-invasive or invasive...

Lack of Inpatient Psychiatric Services Forces Hundreds of Suicidal Teens to Spend Nights in ERs

Published: May 10, 2022
May 10, 2022 As the mental health crisis continues to wear on in the U.S., an increasing number of youth are vying for a limited number of treatment openings. The situation can become even worse when those individuals are mandated such treatment by emergency room doctors. At Bosto...

FDA Restricts Use of J&J’s COVID-19 Vaccine over Blood Clot Risk

Published: May 9, 2022
May 9, 2022 On Thursday, the U.S. Food and Drug Administration (FDA) announced that it had limited the authorized use of the Johnson & Johnson (J&J; also referred to as Janssen) COVID-19 vaccine due to the risk of developing thrombosis with thrombocytopenia syndrome (TTS), a d...

Providers Make Up for Language Barrier Shortcomings in Current Telehealth Services

Published: May 5, 2022
May 5, 2022 While the expansion of telehealth services has improved access to care for many Americans, it has also ushered in a new set of challenges for others. One such issue relates to individuals who don't speak English and others who have limited English speaking skills facing ht...

Fentanyl, Lack of Access to Life-Saving Drugs Present Major Issues in Battle against Opioid Crisis

Published: May 3, 2022
May 3, 2022 While over the past 10 years, the New Jersey Legislature has passed dozens of bills aimed at expanding access to treatment, education, and life-saving drugs like naloxone, as well as changing how many drug crimes are ...

Reports Further Substantiates Youth Mental Health Crisis as Adolescent Suicides Spike in New Jersey

Published: May 2, 2022
May 2, 2022 A new report published in JAMA found that the COVID-19 pandemic has only worsened an already existing mental health crisis among youth in the U.S. The issue is particularly relevant in New Jersey, which was one of only five states included in the study that witnessed a ...

75% of Kids in the U.S. Have Had COVID-19, CDC Estimates

Published: Apr 28, 2022
April 28, 2022 An early release of a report by the Centers for Disease Control and Prevention (CDC) on Tuesday estimated that three out of every four children in the U.S. have been infected with COVID-19 at one point since the pandemic began. In addition to approximately 75% of all...

NJAMHAA and Members Sponsor 35th Anniversary Celebration of the SBYSP

Updated: Apr 26, 2022
April 26, 2022 Please join in the virtual 35th Anniversary Celebration of the School-Based Youth Services Program (SBYSP) on April 27th at 4:00 p.m. Sponsors of this program are NJAMHAA; three NJAMHAA me...

Biden Admin. Releases National Drug Control Strategy with Emphasis on Harm Reduction and Treatment

Published: Apr 25, 2022
April 25, 2022 On Thursday, President Joe Biden released and directed to Congress his Administration's National Drug Control Strategy, which proposes targeted actions to expand access to evidence-based prevention, harm reduction, treatment and recovery services, while reducing the ...
Facebook Twitter LinkedIn Youtube
© NJAMHAA 2024 - powered by EggZack